GPI to be chief sponsors at IMAS', Access 2023

3-5 April 2023, Miami, United States

GPI are thrilled to be chief sponsors of Access 2023, hosted by IMAS and held in Miami, Florida from 3-5 April 2023. GPI will be on stand number 1, and our representatives will be on hand to discuss how GPI can optimise your pricing and market access decision-making in 2022, 2023 and beyond. In addition we will be discussing our innovative research on orphan drugs – utilising the only value assessment and price prediction platform on the market. Details below!

Over 400 market access professionals will be at the ACCESS 2023 Annual Meeting & Expo, organized by the International Market Access Society (IMAS). The conference brings together leaders and innovators from across industry, academia and agencies to share best practices and shape the patient access framework to therapies globally.

Visit our stand at Access 2023

Come and visit our stand (1) to find out about THE ONLY value assessment and price prediction platform on the market! We will be providing demonstrations and discussing the platform, in addition to showcasing how the horizon methodology can minimise the risk of your drug launch, reduce time-intensive payer research and maximise commercial success.

In addition, find out how we utilise data from GPI pulse™ for value, price, and market access insights – with a live demos. Our GPI pulse™ team will be at the conference to discuss and demonstrate how GPI pulse™ can help create more efficient, evidence-led market access strategies.

You will also be able to discuss pricing and market access challenges, stakeholder relationships discover innovative tools and solutions for the ecosystem. Most notably, GPI’s innovative suite of technological and service-based solutions, GPI pulse™ data analytics platform, and our unique platform solution, based on our award-winning methodology that quantifies an asset’s position in the market.

See our Research

GPI will be presenting two research posters at Access 2023 as part of our ongoing research programme.

Abstract #5001:

Title: Importance of time horizon and analogue selection for value-based pricing of cell and gene therapies

  • Presenter onsite: Kate Anstee
  • Logistical Details of Poster Presentation:
    • Presentation Date & Time: Wednesday, April 5 from 10:10 – 10:40 AM EST
    • Location: Poster Room (Glimmer 4, 4th floor)

Abstract #5002:

Title: Faster access and reimbursement for innovative therapies through early access programs in China

  • Presenter onsite: Kate Anstee
    • Presentation Date & Time: Wednesday, April 5 from 12:20 – 12:50 PM EST
    • Location: Poster Room (Glimmer 4, 4th floor)

Share the Article:

Sign up to our mailing list to be informed of the latest webinars